Mechanistic Insights Into the Differential Efficacy of Daptomycin Plus β-Lactam Combinations Against Daptomycin-Resistant Enterococcus faecium.

The Journal of Infectious Diseases
Razieh KebriaeiMichael J Rybak

Abstract

The combination of daptomycin (DAP) plus ampicillin (AMP), ertapenem (ERT), or ceftaroline has been demonstrated to be efficacious against a DAP-tolerant Enterococcus faecium strain (HOU503). However, the mechanism for the efficacy of these combinations against DAP-resistant (DAP-R) E. faecium strains is unknown. We investigated the efficacy of DAP in combination with AMP, ERT, ceftaroline, ceftriaxone, or amoxicillin against DAP-R E. faecium R497 using established in vitro and in vivo models. We evaluated pbp expression, levels of penicillin-binding protein (PBP) 5 (PBP5) and β-lactam binding affinity in HOU503 versus R497. DAP plus AMP was the only efficacious regimen against DAP-R R497 and prevented emergence of resistance. DAP at 8, 6, and 4 mg/kg in combination with AMP was efficacious but showed delayed killing compared with 10 mg/kg. PBP5 of HOU503 exhibited amino acid substitutions in the penicillin-binding domain relative to R497. No difference in pbp mRNA or PBP5 levels was detected between HOU503 and R497. labeling of PBPs with Bocillin FL, a fluorescent penicillin derivative, showed increased β-lactam binding affinity of PBP5 of HOU503 compared with that of R497. Only DAP (10 mg/kg) plus AMP or amoxicillin was effic...Continue Reading

References

Apr 17, 2001·Antimicrobial Agents and Chemotherapy·L B RiceS D Rudin
Dec 25, 2003·Antimicrobial Agents and Chemotherapy·Nasia SafdarW A Craig
Jul 27, 2004·Antimicrobial Agents and Chemotherapy·Louis B RiceLaurent Gutmann
Aug 13, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hilmar WisplinghoffMichael B Edmond
Apr 2, 2008·Antimicrobial Agents and Chemotherapy·Nicole CotroneoJared A Silverman
Feb 17, 2009·Journal of Hepato-biliary-pancreatic Surgery·Fausto CatenaA D Pinna
Nov 18, 2009·Antimicrobial Agents and Chemotherapy·Xavier HenryBernard Joris
Jun 24, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C A AriasB E Murray
Sep 9, 2011·The New England Journal of Medicine·Cesar A AriasGeorge M Weinstock
Mar 20, 2013·Antimicrobial Agents and Chemotherapy·Jose M MunitaCesar A Arias
May 29, 2014·Antimicrobial Agents and Chemotherapy·Lorena DiazCesar A Arias
Sep 4, 2014·Antimicrobial Agents and Chemotherapy·Ester PiettaBarbara E Murray
Sep 24, 2014·The Journal of Antimicrobial Chemotherapy·Katie E BarberMichael J Rybak
Sep 16, 2015·Antimicrobial Agents and Chemotherapy·Diana PanessoCesar A Arias
May 14, 2016·World Journal of Virology·Muthannan Andavar Ramakrishnan
Nov 9, 2016·Antimicrobial Agents and Chemotherapy·Maria Camila MontealegreBarbara E Murray
May 17, 2019·Journal of Clinical Microbiology·Romney M Humphries
Jul 25, 2019·Antimicrobial Agents and Chemotherapy·Amy G PraterYousif Shamoo
Dec 11, 2019·Proceedings of the National Academy of Sciences of the United States of America·Ayesha KhanCesar A Arias

❮ Previous
Next ❯

Citations

Aug 17, 2021·Antimicrobial Agents and Chemotherapy·Razieh KebriaeiMichael J Rybak

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.